A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery.
Clinical trial NCT05524051 · TERMINATED
Trial details
- NCT number
- NCT05524051
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-03
- Primary completion
- 2025-03-26
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.